NSCLC, STAGE I
Clinical trials for NSCLC, STAGE I explained in plain language.
Never miss a new study
Get alerted when new NSCLC, STAGE I trials appear
Sign up with your email to follow new studies for NSCLC, STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy before lung surgery shows promise in early trial
Disease control CompletedThis study tested giving immunotherapy drugs (nivolumab alone or with relatlimab) for four weeks before surgery in 90 people with early-stage non-small cell lung cancer. The goal was to see if this approach is feasible and helps shrink tumors before removal. Results help determin…
Matched conditions: NSCLC, STAGE I
Phase: PHASE2 • Sponsor: University Hospital, Essen • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New combo therapy aims to keep early lung cancer from returning
Disease control CompletedThis study tested whether giving the drug durvalumab after precise radiation therapy (SBRT) helps people with early-stage lung cancer stay cancer-free longer. About 106 patients with stage I non-small cell lung cancer who could not have surgery or chose not to were randomly assig…
Matched conditions: NSCLC, STAGE I
Phase: PHASE2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC